Medistim Competitors

Stocks . Norway . 
Stock . Medistim ASA
MEDI Stock  NOK 185.00  5.50  3.06%   
Medistim ASA competes with Kongsberg Gruppen, Elkem ASA, Integrated Wind, Golden Ocean, and Vow ASA; as well as few others. The company operates under Healthcare sector and is part of Medical Devices industry. Analyzing Medistim ASA competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Medistim ASA to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Medistim ASA Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Medistim ASA competition on your existing holdings.
  
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Medistim ASA's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
182.75185.00187.25
Details
Intrinsic
Valuation
LowRealHigh
152.64154.89203.50
Details
Naive
Forecast
LowNextHigh
190.25192.50194.76
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
170.48178.09185.70
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Medistim ASA. Your research has to be compared to or analyzed against Medistim ASA's peers to derive any actionable benefits. When done correctly, Medistim ASA's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Medistim ASA.

Medistim ASA Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Medistim ASA and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Medistim and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Medistim ASA does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
SOFF
+ 0.88
KOG
GOGL
+ 0.87
KOG
SOFF
+ 0.86
GOGL
NO0010337629
+ 0.8
KOG
GOGL
+ 0.75
NO0010337629
SCATC
+ 0.7
KOG
  
High negative correlations   
VOW
- 0.69
GOGL
VOW
- 0.64
NO0010337629
VOW
- 0.6
KOG
NORTH
- 0.51
VOW
VOW
- 0.45
ELK
SOFF
- 0.43
VOW

Risk-Adjusted Indicators

There is a big difference between Medistim Stock performing well and Medistim ASA Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Medistim ASA's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Medistim ASA Competitive Analysis

The better you understand Medistim ASA competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Medistim ASA's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Medistim ASA's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
MEDI KOG ELK NO0010337629 IWS GOGL VOW NORTH SCATC SOFF
 3.06 
 185.00 
Medistim
 1.31 
 887.00 
Kongsberg
 2.49 
 21.12 
Elkem
 0.00 
 1,054 
DNBNORKAPFORVKREDITTOBLIGASJON
 5.98 
 44.00 
Integrated
 9.88 
 150.50 
Golden
 0.17 
 5.81 
Vow
 0.45 
 2.24 
North
 5.48 
 77.90 
Scatec
 6.21 
 42.30 
Solstad
Market Volatility
(90 Days Market Risk)
Very steady
Very steady
Not too volatile
Very steady
Very steady
Very steady
Unstable
Risky
Very steady
Very steady
Market Performance
(90 Days Performance)
Very Weak
Solid
Modest
Solid
Very Weak
Good
Very Weak
Weak
OK
OK
Odds of Financial Distress
(Probability Of Bankruptcy)
Low
Low
Low
Unknown
Low
Low
Low
Low
Below Average
Below Average
Current Valuation
(Equity Enterprise Value)
Over Valued
Under Valued
Over Valued
Over Valued
Fairly Valued
Under Valued
Over Valued
Over Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Strong Buy
Strong Sell
Sell
Cautious Hold
Strong Buy
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Current Ratio
3.68
1.93
2.14
N/A
0.72
3.55
49.95
2.32
0.1
Net Asset
403.24 M
39.31 B
52.78 B
756 M
3.45 B
1.11 B
338.99 M
33.03 B
24.94 B
Profit Margin
0.21
0.0815
0.21
-0.12
0.48
0.52
N/A
-0.44
-0.33
EBITDA
137.68 M
4.22 B
13.48 B
(11.76 M)
691.22 M
357.9 M
(45.12 M)
2.89 B
1.24 B
Operating Margin
0.27
0.1
0.26
-0.11
0.43
0.0716
-143.76
0.31
0.0789
Current Valuation
4.12 B
73.95 B
25.67 B
539.9 M
29.68 B
2.36 B
97.1 M
32.49 B
23.44 B
Price To Book
12.24
5.88
0.77
0.95
0.92
3.87
0.77
1.47
2.25
Current Asset
136 M
12.92 B
N/A
N/A
251 M
N/A
730 M
N/A
1.77 B
Five Year Return
2.62
2.86
N/A
N/A
10.66
N/A
N/A
N/A
N/A
Retained Earnings
N/A
6.38 B
N/A
N/A
282 M
N/A
(698 M)
N/A
N/A
Beta
0.75
0.37
1.59
N/A
1.32
1.37
0.98
1.22
2.99
Number Of Employees
116
11.77 K
7.3 K
48
37
232
2
800
3.6 K
Shares Outstanding
18.26 M
176.58 M
635.52 M
39.14 M
200.42 M
113.84 M
117.25 M
158.92 M
77.31 M
Cash Flow From Operations
128.14 M
4.97 B
9.31 B
(26.56 M)
560.4 M
18 M
(15.6 M)
2.07 B
1.38 B
Annual Yield
0.0164
0.0087
0.16
N/A
0.22
N/A
0.16
0.0238
N/A
Total Debt
17.08 M
3.95 B
10.33 B
14.26 M
1.26 B
251.4 M
2.54 M
17.97 B
17.81 B
Return On Equity
0.31
0.2
0.4
-0.0489
0.31
0.64
-0.038
-0.13
-0.9
Z Score
N/A
10.8
1.2
54.6
9.0
5.4
59.0
N/A
N/A
Return On Asset
0.2
0.0494
0.15
-0.0233
0.096
0.0255
-0.0351
0.0165
0.0113
Book Value Per Share
18.94
68.79
45.14
35.49
9.57
4.56
2.84
52.0
12.46
Current Liabilities
43 M
9.45 B
N/A
N/A
154 M
N/A
584 M
N/A
2.69 B
Total Asset
403.24 M
39.31 B
52.78 B
756 M
3.45 B
1.11 B
338.99 M
33.03 B
24.94 B
Debt To Equity
3.4
46.2
85.6
N/A
90.1
0.59
1.4
2.13
872.2
Target Price
290.0
410.0
44.4
53.0
0.9
22.0
1.1
104.3
33.0
Last Dividend Paid
3.75
3.3
6.0
N/A
2.35
N/A
N/A
1.94
N/A
Shares Owned By Institutions
73.95
24.27
27.78
25.43
33.02
7.89
0.01
47.63
8.71
Market Capitalization
4.24 B
72.57 B
24.28 B
1.3 B
19.43 B
2.35 B
263.82 M
12.34 B
3.85 B
Price To Earning
36.32
20.98
6.16
N/A
134.86
88.42
34.04
N/A
-0.29
Price To Earnings To Growth
N/A
1.58
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Price To Sales
9.15
2.35
0.49
4.71
14.62
3.07
1838.92
4.5
0.37
Net Income
90.9 M
2.16 B
12.41 B
(17.91 M)
527.22 M
322.3 M
(27.83 M)
388 M
(1.1 B)
Earnings Per Share
5.34
13.93
16.77
-1.39
30.83
2.95
0.29
-4.84
-13.61
Shares Owned By Insiders
14.97
53.74
55.4
33.61
39.16
62.5
61.06
26.81
47.05
Revenue
417.82 M
27.45 B
45.02 B
51.35 M
1.2 B
454.1 M
178 K
3.04 B
5.13 B
Working Capital
93 M
3.47 B
N/A
N/A
97 M
N/A
146 M
N/A
(922 M)
Cash And Equivalents
129.49 M
10.39 B
9.26 B
388.88 M
139.29 M
303 M
39.99 M
4.08 B
2.46 B
Cash Per Share
2.99
57.72
9.23
33.78
0.97
2.65
2.15
26.38
2.74
Gross Profit
320.7 M
17.87 B
23.64 B
2.16 M
649.86 M
171.6 M
178 K
3 B
2.81 B
Day Typical Price
183.17
887.33
21.36
1053.73
44.0
155.03
5.79
2.23
76.62
43.46
Accumulation Distribution
0.0297
0.019
0.0384
N/A
N/A
0.11
0.062
0.0134
0.0875
0.0836
Market Facilitation Index
5.5
17.0
0.84
N/A
N/A
18.6
0.37
0.03
6.95
3.84
Daily Balance Of Power
1.0
0.6765
(0.64)
0.0
(9,223,372,036,855)
(0.89)
0.027
0.3333
0.5827
(0.73)
Period Momentum Indicator
5.5
11.5
(0.54)
N/A
(2.80)
(16.50)
0.01
0.01
4.05
(2.80)
Rate Of Daily Change
1.03
1.01
0.98
1.0
0.94
0.9
1.0
1.0
1.05
0.94
Day Median Price
182.25
887.5
21.48
1053.73
44.0
157.3
5.79
2.23
75.97
44.04
Price Action Indicator
5.5
5.25
(0.63)
N/A
(1.40)
(15.05)
0.03
0.02
3.95
(3.14)
Coefficient Of Variation
(1,637)
280.68
5020.95
738.93
(7,613)
584.22
(879.99)
1310.9
1760.14
876.51
Mean Deviation
1.5
1.06
1.53
0.1336
1.71
1.91
3.79
1.79
2.18
2.44
Jensen Alpha
(0.15)
0.5182
0.0458
0.0129
(0.12)
0.3746
(0.80)
0.2156
0.2007
0.3495
Total Risk Alpha
(0.39)
0.3604
(0.22)
(0.01)
(0.39)
0.1253
(1.40)
(0.12)
(0.20)
(0.02)
Sortino Ratio
N/A
0.2268
(0.02)
(0.35)
N/A
0.1546
N/A
0.0574
0.0324
0.0972
Downside Variance
N/A
4.41
3.55
0.0253
N/A
5.43
N/A
5.06
9.09
8.76
Standard Deviation
2.14
1.56
2.1
0.1641
2.93
2.56
5.97
2.72
3.09
3.21
Kurtosis
3.48
2.83
1.24
(0.54)
2.19
4.76
4.47
6.74
1.47
0.3174
Potential Upside
2.94
2.75
3.42
0.2766
5.43
3.8
9.15
4.46
5.48
5.94
Treynor Ratio
(2.07)
1.41
(0.16)
(1.25)
(0.05)
0.5431
(0.41)
(0.73)
(0.32)
3.77
Maximum Drawdown
11.75
9.3
11.8
0.7136
16.57
12.3
36.0
18.69
17.58
13.21
Variance
4.59
2.42
4.43
0.0269
8.58
6.56
35.69
7.37
9.56
10.29
Market Risk Adjusted Performance
(2.06)
1.42
(0.15)
(1.24)
(0.04)
0.5531
(0.40)
(0.72)
(0.31)
3.78
Risk Adjusted Performance
(0.03)
0.2112
0.0187
0.0528
5.0E-4
0.1062
(0.06)
0.0517
0.0408
0.0738
Skewness
(1.12)
(0.86)
0.4255
(0.11)
0.4312
(0.20)
(0.81)
1.68
0.3475
0.1221
Semi Deviation
N/A
1.16
1.82
0.0051
N/A
2.05
N/A
1.93
2.84
2.63
Information Ratio
(0.1)
0.3061
(0.02)
(0.34)
(0.04)
0.1407
(0.13)
0.0475
0.0316
0.0898
Value At Risk
(3.39)
(2.09)
(3.27)
(0.25)
(4.74)
(2.36)
(7.46)
(3.42)
(4.85)
(5.23)
Expected Short fall
N/A
(1.19)
(1.79)
(0.15)
N/A
(2.26)
N/A
(2.24)
(2.29)
(2.72)
Downside Deviation
N/A
2.1
1.88
0.159
N/A
2.33
N/A
2.25
3.02
2.96
Semi Variance
N/A
1.34
3.31
0.0
N/A
4.2
N/A
3.72
8.06
6.93

Medistim ASA Competition Performance Charts

Five steps to successful analysis of Medistim ASA Competition

Medistim ASA's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Medistim ASA in relation to its competition. Medistim ASA's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Medistim ASA in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Medistim ASA's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Medistim ASA, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Medistim ASA position

In addition to having Medistim ASA in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Iron Thematic Idea Now

Iron
Iron Theme
Companies involved in production of steel and iron. The Iron theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Iron Theme or any other thematic opportunities.
View All  Next Launch
Check out Medistim ASA Correlation with its peers.
You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Complementary Tools for Medistim Stock analysis

When running Medistim ASA's price analysis, check to measure Medistim ASA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medistim ASA is operating at the current time. Most of Medistim ASA's value examination focuses on studying past and present price action to predict the probability of Medistim ASA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medistim ASA's price. Additionally, you may evaluate how the addition of Medistim ASA to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Fundamental Analysis
View fundamental data based on most recent published financial statements
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Altman
Z Score
Details
Intrinsic
Valuation
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Technical
Analysis
Details
Please note, there is a significant difference between Medistim ASA's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medistim ASA is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medistim ASA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY